Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.

NTCP expression is linearly correlated with fibrosis severity. Modulated BA trafficking could be an important step in LF pathogenesis. Antagonising BA uptake may suggest a therapeutic strategy for preventing disease progression.